U.S. markets open in 9 hours 5 minutes
  • S&P Futures

    4,160.50
    -23.00 (-0.55%)
     
  • Dow Futures

    34,565.00
    -103.00 (-0.30%)
     
  • Nasdaq Futures

    13,229.00
    -127.75 (-0.96%)
     
  • Russell 2000 Futures

    2,182.20
    -27.40 (-1.24%)
     
  • Crude Oil

    64.46
    -0.46 (-0.71%)
     
  • Gold

    1,835.50
    -2.10 (-0.11%)
     
  • Silver

    27.43
    -0.06 (-0.21%)
     
  • EUR/USD

    1.2146
    +0.0012 (+0.10%)
     
  • 10-Yr Bond

    1.6020
    +0.0250 (+1.59%)
     
  • Vix

    19.66
    +2.97 (+17.80%)
     
  • GBP/USD

    1.4128
    +0.0006 (+0.04%)
     
  • USD/JPY

    108.8870
    +0.0460 (+0.04%)
     
  • BTC-USD

    55,417.11
    -3,783.99 (-6.39%)
     
  • CMC Crypto 200

    1,459.97
    -101.33 (-6.49%)
     
  • FTSE 100

    7,123.68
    -6.03 (-0.08%)
     
  • Nikkei 225

    28,633.82
    -884.52 (-3.00%)
     

Russia's RDIF signs deal to produce Sputnik V vaccine in China

MOSCOW, March 29 (Reuters) - Russia's RDIF sovereign wealth fund and China's Shenzhen Yuanxing Gene-tech have agreed to produce over 60 million doses of Russia's Sputnik V vaccine against COVID-19 in China, RDIF said on Monday.

RDIF, which is marketing Sputnik V globally, said that commercial production was due to start in May. (Reporting by Maria Kiselyova; writing by Tom Balmforth; editing by Louise Heavens)